Arrowpoint Investment Partners »

Ptc Therapeutics I shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $202k 3.3k 61.37

More positions owned by Arrowpoint Investment Partners

Aegon Amer Reg 1 Cert (AEG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Hallador Energy (HNRG)
Echostar Corp Cl A (SATS)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Astera Labs (ALAB)
Atour Lifestyle Hldgs Sponsored Ads (ATAT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Bristol Myers Squibb Call Option (BMY)
Merck & Co Call Option (MRK)
Pfizer Call Option (PFE)
Abbvie Call Option (ABBV)
Hesai Group Sponsored Ads (HSAI)
Comfort Systems USA (FIX)

View all positions for Arrowpoint Investment Partners

Top funds holding Ptc Therapeutics I

Vanguard Group
Rtw Investments
BlackRock
Wellington Management Company
Henderson Group
Armistice Capital
Toronto-Dominion Bank
State Street Corporation
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
FMR
Leucadia National Corporation
Tang Capital Management
Pictet Asset Management Holding SA

View all funds holding Ptc Therapeutics I